303 related articles for article (PubMed ID: 12031966)
1. Hepatocyte nuclear factor-1alpha modulates pancreatic beta-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells.
Yang Q; Yamagata K; Fukui K; Cao Y; Nammo T; Iwahashi H; Wang H; Matsumura I; Hanafusa T; Bucala R; Wollheim CB; Miyagawa J; Matsuzawa Y
Diabetes; 2002 Jun; 51(6):1785-92. PubMed ID: 12031966
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of dominant-negative mutant hepatocyte nuclear fctor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetes.
Yamagata K; Nammo T; Moriwaki M; Ihara A; Iizuka K; Yang Q; Satoh T; Li M; Uenaka R; Okita K; Iwahashi H; Zhu Q; Cao Y; Imagawa A; Tochino Y; Hanafusa T; Miyagawa J; Matsuzawa Y
Diabetes; 2002 Jan; 51(1):114-23. PubMed ID: 11756330
[TBL] [Abstract][Full Text] [Related]
3. Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative.
Yamagata K; Yang Q; Yamamoto K; Iwahashi H; Miyagawa J; Okita K; Yoshiuchi I; Miyazaki J; Noguchi T; Nakajima H; Namba M; Hanafusa T; Matsuzawa Y
Diabetes; 1998 Aug; 47(8):1231-5. PubMed ID: 9703322
[TBL] [Abstract][Full Text] [Related]
4. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.
Richter S; Shih DQ; Pearson ER; Wolfrum C; Fajans SS; Hattersley AT; Stoffel M
Diabetes; 2003 Dec; 52(12):2989-95. PubMed ID: 14633861
[TBL] [Abstract][Full Text] [Related]
5. Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line.
Wang H; Maechler P; Hagenfeldt KA; Wollheim CB
EMBO J; 1998 Nov; 17(22):6701-13. PubMed ID: 9822613
[TBL] [Abstract][Full Text] [Related]
6. Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice.
Pontoglio M; Sreenan S; Roe M; Pugh W; Ostrega D; Doyen A; Pick AJ; Baldwin A; Velho G; Froguel P; Levisetti M; Bonner-Weir S; Bell GI; Yaniv M; Polonsky KS
J Clin Invest; 1998 May; 101(10):2215-22. PubMed ID: 9593777
[TBL] [Abstract][Full Text] [Related]
7. Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism.
Shih DQ; Screenan S; Munoz KN; Philipson L; Pontoglio M; Yaniv M; Polonsky KS; Stoffel M
Diabetes; 2001 Nov; 50(11):2472-80. PubMed ID: 11679424
[TBL] [Abstract][Full Text] [Related]
8. Molecular targets of a human HNF1 alpha mutation responsible for pancreatic beta-cell dysfunction.
Wang H; Antinozzi PA; Hagenfeldt KA; Maechler P; Wollheim CB
EMBO J; 2000 Aug; 19(16):4257-64. PubMed ID: 10944108
[TBL] [Abstract][Full Text] [Related]
9. Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3).
Boileau P; Wolfrum C; Shih DQ; Yang TA; Wolkoff AW; Stoffel M
Diabetes; 2002 Dec; 51 Suppl 3():S343-8. PubMed ID: 12475773
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of dominant negative mutant hepatocyte nuclear factor (HNF)-1alpha inhibits arginine-induced insulin secretion in MIN6 cells.
Tanizawa Y; Ohta Y; Nomiyama J; Matsuda K; Tanabe K; Inoue H; Matsutani A; Okuya S; Oka Y
Diabetologia; 1999 Jul; 42(7):887-91. PubMed ID: 10440133
[TBL] [Abstract][Full Text] [Related]
11. Profound defects in pancreatic beta-cell function in mice with combined heterozygous mutations in Pdx-1, Hnf-1alpha, and Hnf-3beta.
Shih DQ; Heimesaat M; Kuwajima S; Stein R; Wright CV; Stoffel M
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3818-23. PubMed ID: 11904435
[TBL] [Abstract][Full Text] [Related]
12. Human insulin gene is a target gene of hepatocyte nuclear factor-1alpha (HNF-1alpha) and HNF-1beta.
Okita K; Yang Q; Yamagata K; Hangenfeldt KA; Miyagawa J; Kajimoto Y; Nakajima H; Namba M; Wollheim CB; Hanafusa T; Matsuzawa Y
Biochem Biophys Res Commun; 1999 Sep; 263(2):566-9. PubMed ID: 10491332
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dysfunction contributes to impaired insulin secretion in INS-1 cells with dominant-negative mutations of HNF-1alpha and in HNF-1alpha-deficient islets.
Pongratz RL; Kibbey RG; Kirkpatrick CL; Zhao X; Pontoglio M; Yaniv M; Wollheim CB; Shulman GI; Cline GW
J Biol Chem; 2009 Jun; 284(25):16808-16821. PubMed ID: 19376774
[TBL] [Abstract][Full Text] [Related]
14. Dominant-negative suppression of HNF-1 alpha results in mitochondrial dysfunction, INS-1 cell apoptosis, and increased sensitivity to ceramide-, but not to high glucose-induced cell death.
Wobser H; Düssmann H; Kögel D; Wang H; Reimertz C; Wollheim CB; Byrne MM; Prehn JH
J Biol Chem; 2002 Feb; 277(8):6413-21. PubMed ID: 11724785
[TBL] [Abstract][Full Text] [Related]
15. Beta-cell-targeted expression of a dominant-negative hepatocyte nuclear factor-1 alpha induces a maturity-onset diabetes of the young (MODY)3-like phenotype in transgenic mice.
Hagenfeldt-Johansson KA; Herrera PL; Wang H; Gjinovci A; Ishihara H; Wollheim CB
Endocrinology; 2001 Dec; 142(12):5311-20. PubMed ID: 11713231
[TBL] [Abstract][Full Text] [Related]
16. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
[TBL] [Abstract][Full Text] [Related]
17. Counterregulatory responses to hypoglycemia in patients with maturity-onset diabetes of the young caused by HNF-1alpha gene mutations (MODY3).
Guenat E; Seematter G; Philippe J; Temler E; Jéquier E; Tappy L
Eur J Endocrinol; 2001 Jan; 144(1):45-9. PubMed ID: 11174836
[TBL] [Abstract][Full Text] [Related]
18. Identification and functional characterization of a novel mutation of hepatocyte nuclear factor-1alpha gene in a Korean family with MODY3.
Kim KA; Kang K; Chi YI; Chang I; Lee MK; Kim KW; Shoelson SE; Lee MS
Diabetologia; 2003 May; 46(5):721-7. PubMed ID: 12712243
[TBL] [Abstract][Full Text] [Related]
19. Experimental models of transcription factor-associated maturity-onset diabetes of the young.
Wang H; Hagenfeldt-Johansson K; Otten LA; Gauthier BR; Herrera PL; Wollheim CB
Diabetes; 2002 Dec; 51 Suppl 3():S333-42. PubMed ID: 12475772
[TBL] [Abstract][Full Text] [Related]
20. Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation.
Hansen T; Eiberg H; Rouard M; Vaxillaire M; Møller AM; Rasmussen SK; Fridberg M; Urhammer SA; Holst JJ; Almind K; Echwald SM; Hansen L; Bell GI; Pedersen O
Diabetes; 1997 Apr; 46(4):726-30. PubMed ID: 9075819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
